Pregnancy: CNS complications …

Adrian Marchidann MD

General Neurology

Updated 01.20.2024
Released 02.02.2000
Expires For CME 01.20.2027

Pregnancy: CNS complications

Author: Adrian Marchidann MD

See Contributor Disclosures

Editor: Peter J Koehler MD PhD

Pregnancy: CNS complications

In This Article

Quick Link

Introduction

Overview

Given the potentially severe consequences on the mother’s neurologic health, pregnancy may pose a serious challenge. Similarly, the postpartum period carries with it significant and unique neurologic risks. In this article, the common central nervous system complications during pregnancy and the postpartum period are reviewed, with an emphasis on eclampsia and stroke.

Key points

	• Pregnancy and delivery trigger physiologic changes resulting in specific complications or modifying the course of neurologic disorders.
	• Intractable vomiting may cause Wernicke encephalopathy, a potentially fatal condition that requires early recognition and urgent administration of thiamine.
	• Most untreated or insufficiently treated survivors of Wernicke encephalopathy develop Korsakoff syndrome, characterized by anterograde and retrograde amnesia.
	• The risk of ischemic and hemorrhagic stroke is elevated, mostly peripartum and postpartum.
	• In young pregnant women, stroke shares the same risk factors with elderly women but is mostly caused by venous thrombosis, reversible cerebral vasoconstriction, and preeclampsia/eclampsia.
	• Although pregnant women were excluded from the thrombolysis clinical trials, ischemic stroke was treated successfully with tPA in several cases.
	• Stroke due to large vessel occlusion may benefit from endovascular thrombectomy guided by imaging.
	• Low-dose aspirin may cause gastroschisis during the first trimester but is safe thereafter for prevention of ischemic stroke.
	• Preeclampsia can be prevented by blood pressure control and low-dose aspirin; eclampsia responds to intravenous magnesium sulfate.
	• Heparin given subcutaneously is preferably used in thrombophilia and cardioembolism, but not mechanical mitral valve, which requires warfarin.
	• Subarachnoid hemorrhage management is according to the guidelines for nonpregnant women.

Historical note and terminology

The physiologic changes occurring during pregnancy and puerperium can affect the central nervous system and complicate the management of preexisting neurologic conditions. The effect of pregnancy on chronic neurologic conditions, such as epilepsy, multiple sclerosis, myasthenia gravis, and migraine, are not addressed in this article.

The complications of peripartum anesthesia are difficult to distinguish from those of pregnancy. Headaches following dural puncture and cerebrospinal fluid leak are the most frequent CNS complications of anesthesia. A retrospective cohort study consisting of 1,003,803 pregnant women who received neuraxial anesthesia revealed that headache may be caused by cerebral venous thrombosis, subdural hematoma, meningitis, and depression. Seventy percent of cerebral venous thrombosis and subdural hematoma were diagnosed during readmission after a median interval of 5 days (63).

Spinal cord lesions due to trauma, compression, ischemia, or total spinal block occur rarely, but the severity of these complications demands early recognition and rapid intervention. Seizures during anesthesia may be triggered by selective inhibition of the inhibitory neurons.

Wernicke encephalopathy, a potentially fatal, yet treatable complication of thiamine deficiency, was described initially by Carl Wernicke in 1881 in two alcoholic patients and one woman with intractable vomiting from gastric stenosis caused by sulfuric acid ingestion (89). Its association with hyperemesis gravidarum was later noted (143). In 1888 Sir William Gowers described eclampsia or toxemia of pregnancy characterized by convulsions in pregnant women with hypertension, proteinuria, and edema. This syndrome is uniquely associated with pregnancy-induced hypertension. In 1899, Edward Lazard discovered during autopsy the first intracerebral hemorrhage in pregnancy caused by a ruptured aneurysm. John Abercrombie made the first autopsy description of puerperal cerebral phlebothrombosis in 1828; however, the first clinical description of central venous thrombosis was made by Gowers in 1893.

Clinical manifestations

Presentation and course

	• Wernicke encephalopathy often presents with decreased consciousness or coma.
	• Stroke produces focal neurologic deficits corresponding to the areas affected.
	• Preeclampsia occurs when high blood pressure is associated with neurologic deficits and oftentimes proteinuria.
	• Seizures in patients with preeclampsia are the hallmark of eclampsia.
	• There is an overlap between preeclampsia, posterior reversible encephalopathy, reversible cerebral vasoconstriction syndrome, and HELLP.

Wernicke encephalopathy. Wernicke encephalopathy manifests as decreased consciousness, ataxia, nystagmus, and ophthalmoparesis. Thiamine deficiency develops rapidly in those with intractable vomiting. In a single center series of 8735 autopsies performed over 5 years in Oslo, Wernicke encephalopathy was diagnosed in 70 cases (0.8%). Of these, 22 had acute and subacute presentation, and the rest were chronic (Korsakoff syndrome). Stupor and coma were the dominating symptoms in active cases (139). If seizures occur, EEG reveals generalized epileptogenic activity (106). Due to its various presentations, Wernicke encephalopathy may be confused with depression (130).

In a retrospective analysis, only 16% of 131 cases diagnosed by necropsy had the classical clinical triad documented (68). If untreated, Korsakoff syndrome may develop, characterized by severe anterograde and retrograde amnesia associated with confabulation in the initial stages. A disorientation of time is apparent. The emotional changes consist of apathy or mild euphoria, which respond little to various events (123). Additionally, executive function and emotion perception in others are impaired (08).

Cerebrovascular disease. All types of cerebrovascular disease, including transient ischemic attack, ischemic and hemorrhagic stroke, subarachnoid hemorrhage, dural sinus thrombosis, and cerebral venous thrombosis can occur during pregnancy and puerperium. Clinical presentation ranges from transient focal symptoms to coma and death. The neurologic deficits reflect the location of the insult hemiparesis, hemisensory loss, visual disturbances, neglect, aphasia, or alteration of awareness/coma. Headache and seizures can also occur.

Cerebral venous sinus thrombosis (CVST). Thrombosis of the deep cortical veins and cerebral venous sinuses occurs more often during pregnancy. Venous thrombosis is more often associated with headache (91%), seizures (39%), or increased intracranial pressure, including papilledema (28%), than arterial occlusion (30). Other symptoms include dizziness, nausea, focal neurologic symptoms, lethargy, and coma (19).

Subarachnoid hemorrhage. Subarachnoid hemorrhage is usually caused by a ruptured aneurysm. During preeclampsia, subarachnoid hemorrhage results from the rupture of the small pial veins (155). Subarachnoid hemorrhage may trigger vasospasm, even in absence of an aneurysm (53; 56). A patient who became rapidly comatose after subarachnoid hemorrhage recovered after cesarean section (26). Cortical vein thrombosis may result in infarction and subarachnoid hemorrhage (145).

Preeclampsia and eclampsia. Preeclampsia is defined as systolic blood pressure greater than 140 mmHg or diastolic blood pressure greater than 90 mmHg measured on two occasions, at least 4 hours apart, associated with proteinuria developing after the twentieth week of pregnancy in a woman previously normotensive. If proteinuria is absent, preeclampsia is diagnosed as hypertension associated with new onset of any of the following: thrombocytopenia (< 100x9/L), elevated liver enzymes more than twice the normal concentration, elevation of creatinine more than twice normal or greater than 1.1 mg/dL in absence of other renal disease, pulmonary edema, new onset of unexplained headache, or visual disturbances. Preeclampsia with severe features occurs when systolic or diastolic pressures are greater than 160 or 110 mmHg, respectively, and preeclampsia is associated with end organ damage as described above. In this situation, the confirmatory measurement should be performed after a few minutes to expedite treatment (07).

The focal neurologic manifestations of preeclampsia reflect the location and size of the intracerebral hemorrhage, cerebral edema, and ischemic stroke caused by vasospasm (70; 145; 69). Carotid artery occlusion was described during rebound thrombocytosis of HELLP (83).

The visual symptoms are caused by retinal exudates, hemorrhages, edema, and/or retinal detachment. Cortical blindness has been attributed to microinfarcts and petechial hemorrhages in the visual cortex bilaterally. Symptoms can progress rapidly but generally resolve within 24 hours of delivery. Mortality typically results from large hematomas and severe cerebral edema (81).

Eclampsia occurs when seizures or coma develop in a patient with preeclampsia. Seizures are typically generalized tonic-clonic but may have focal or multifocal features (39). Eclampsia develops antepartum in 50% of patients, during labor in 25% and postpartum in 25%. Most postpartum seizures occur within the first 24 hours; however, they may appear as late as 26 days postpartum.

Posterior reversible encephalopathy syndrome (PRES). This syndrome is characterized by headache, encephalopathy, visual disturbances, and seizures associated with reversible vasogenic edema seen on CT or MRI. The syndrome resolves within 2 weeks (72). Posterior reversible encephalopathy syndrome often accompanies preeclampsia and eclampsia (104). In one center study, 46 of 47 patients (97.9%) with eclampsia had posterior reversible encephalopathy syndrome on neuroimaging (21).

Reversible cerebral vasoconstriction syndrome (RCVS). Patients usually present with multiple thunderclap headaches (reaching maximum intensity within 1 minute), seizures, confusion, visual changes, focal neurologic deficits, and coma. Cerebral vasculature imaging reveals vasoconstriction in at least two arteries that resolves within 3 months (24). Reversible cerebral vasoconstriction syndrome or postpartum angiopathy is sometimes associated with preeclampsia and mimics eclampsia if seizures occur (57).

Both PRES and RCVS may occur at the same time with preeclampsia (133). Whereas recurrent thunderclap headache is characteristic of RCVS, seizures are typical of PRES (128).

Hemolysis, elevated liver function, and low platelets syndrome (HELLP). This syndrome is also associated with preeclampsia. It presents as generalized edema, right upper quadrant or epigastric pain, nausea, and vomiting, which are typically worse at night (12). The neurologic presentations include seizures, neurologic deficits, and encephalopathy (116).

Prognosis and complications

Wernicke encephalopathy. Approximately 80% of untreated survivors of Wernicke encephalopathy related to alcohol abuse develop Korsakoff syndrome. The estimated mortality is 17% (144). Administration of 100 to 250 mg of thiamine daily may not prevent mortality, and up to 84% patients develop Korsakoff syndrome. More than 500 mg administered daily for several days is needed to increase the rate of recovery. In a small case series, complete resolution of symptoms occurred in 7 of 11 patients (111). A systematic review of the case studies, including 177 patients with hyperemesis gravidarum, found chronic cognitive impairment in 64.5%, a pregnancy loss of 50%, and maternal mortality of 5% of all cases. Thiamine supplementation was inadequate in 63.6% of cases (113).

Cerebrovascular disease. The Maternal Mortality Collaborative reported that 8.5% of deaths during pregnancy are related to stroke (05). Moreover, after a live pregnancy, 60% of women died from embolism and pregnancy-induced hypertension (27). Between 2006 and 2010, the proportion of deaths attributable to pregnancy-related conditions decreased, whereas the contribution of cardiovascular risk factors and infection increased (31). In the United Kingdom, the case fatality rate of all strokes was 20% and of hemorrhagic strokes was 50%. The mortality rate of stroke was 0.3 per 100,000 deliveries (122). In the United States between 2000 and 2001, the mortality rate from stroke was 1.4 per 100,000 deliveries (77). However, pregnant women with hemorrhagic stroke had fewer risk factors and better prognosis compared with nonpregnant women (95).

Intracerebral hemorrhage from aneurysm or arteriovenous malformation is responsible for up to 12% of all maternal deaths. Most hemorrhages (92%) occurred in the antepartum. Approximately 77% were caused by a ruptured aneurysm and 22% by arteriovenous malformation (37).

The mortality rate from subarachnoid hemorrhage was estimated at 27% to 40%, whereas the mortality rate from arteriovenous malformations was 28% (37). The prognosis is directly related to severity of neurologic grade at presentation of bleed (150). Data analysis from a National Inpatient Sample from 2010 to 2018 identified 13,351 patients with aneurysmal subarachnoid hemorrhage, of which 440 cases were in pregnant women (84). No difference in mortality or discharge to home was associated with aneurysmal subarachnoid hemorrhage. However, severity of hemorrhage, chronic hypertension, and small hospital were associated with higher mortality.

Cerebral venous sinus thrombosis (CVST). Historically, cerebral venous thrombosis has been associated with a high mortality rate; however, of the patients presenting with cerebral venous sinus thrombosis, 59% had modified Rankin scale (mRS) of 0 and 94% and had mRS of 0 to 2 at follow-up. Headache alone predicted an excellent outcome, whereas obtundation and coma predicted against excellent outcome (82). A multicenter observational study showed that patients with gender-specific risk factors (ie, pregnancy) had a rate of death/dependency of 12% compared with 20% in men and women without such risk factors (30). The cumulative risk of recurrence of thrombotic events, including CVST, is 6.5% (52).

Preeclampsia and eclampsia. Eclampsia causes approximately 60,000 maternal deaths per year worldwide (152). In the United States, the case fatality rate of preeclampsia-eclampsia is 6.4 per 10,000 cases at delivery and is twice as high in black compared to white women (102). Neonatal and maternal complications markedly increase when preeclampsia develops before 32 weeks’ gestation (125). Although most white matter lesions seen on brain MRI resolve, 40% of eclamptic women have persisting lesions at 7-year follow-up, compared to 17% of controls. Additionally, neurocognitive testing after preeclampsia or eclampsia revealed memory impairment (155). Furthermore, data from the Stroke Prevention in Young Women Study found a 60% increased risk of nonpregnancy-related ischemic stroke in women with a history of preeclampsia (23).

Posterior reversible encephalopathy syndrome (PRES). In a retrospective cohort of 70 patients with PRES, 94% had altered consciousness, 81% had seizures, and 14% had ischemic stroke or intracerebral hemorrhage. Most patients (56%) recovered at 90 days but 16% died and 37% had marked functional impairment (97).

Reversible cerebral vasoconstriction syndrome (RCVS). During the first week, cortical subarachnoid hemorrhage (22%), intracerebral hemorrhage (6%), seizures (3%), and reversible posterior leukoencephalopathy (9%) are diagnosed (42). Later, transient ischemic attacks (16%) and cerebral infarction (4%) are diagnosed. The outcome is death in 2% and severe neurologic sequelae in 9% of patients. However, most patients recover significantly within days to weeks (128). Recurrence is exceptional, although 5% can later develop isolated thunderclap headaches with or without mild cerebral vasoconstriction.

Hemolysis, elevated liver function, and low platelets syndrome (HELLP). The prognosis of HELLP is similar to that of severe preeclampsia except for the hematologic variables (65). A retrospective study of 12 patients with HELLP found neurologic complications in eight patients (66%): seizures, focal neurologic deficits, and encephalopathy. Six patients had radiologic evidence of PRES with or without hemorrhagic transformation and isolated intracerebral hemorrhage (116).

Clinical vignette

A 30-year-old primigravida presented at 39 weeks’ gestation with symptoms of early labor. She had no complications with pregnancy. Her only medication was low-dose aspirin for a remote history of a patent foramen ovale and transient visual symptoms. She delivered a healthy male infant with a forceps-assisted vaginal delivery. No symptoms of hypertension, edema, or proteinuria were noted. Approximately 6 hours postpartum, her blood pressure was 180/110 mm Hg and new proteinuria developed. She complained of chest pain and severe headaches. Within a few hours, she developed blurry vision in her right eye, ptosis, and lower extremity numbness. Subsequently, she had a generalized tonic-clonic seizure lasting 30 seconds. She was treated with intravenous diazepam and magnesium sulfate. Blood pressure responded to nitroglycerin.

Laboratory abnormalities were platelet count of 34,000, liver transaminases greater than 1600 mg/dl, prolonged prothrombin time, elevated creatinine, and hemolysis on peripheral blood smear. CT, MRI, and MR angiography showed a right frontal subarachnoid hemorrhage and diffuse cerebral edema. There was no venous thrombosis or arterial occlusion.

T2 hyperintensity (brain MRI) (1)

A sequential axial slice on brain MRI. This FLAIR sequence shows increased T2 hyperintensity in the right basal ganglia and bilateral parietal and occipital lobes during the patient’s acute symptoms. (Contributed by Dr. Nerissa Ko...
T2 hyperintensity (brain MRI) (2)

A sequential axial slice on brain MRI. This FLAIR sequence shows increased T2 hyperintensity in the right basal ganglia and bilateral parietal and occipital lobes during the patient’s acute symptoms. (Contributed by Dr. Nerissa Ko...

The headache and mental status worsened, requiring transfer to the neurointensive care unit. She received mannitol and dexamethasone. The seizures were treated, and her neurologic deficits resolved. Over the next 5 days, her laboratory abnormalities normalized.

This patient illustrates many aspects of severe eclampsia associated with HELLP syndrome. She had rapidly progressive neurologic symptoms in the early postpartum period. Symptoms resolved rapidly with aggressive treatment of hypertension, seizures, and cerebral edema.

Biological basis

	• Hyperemesis gravidarum causes thiamine deficiency, Wernicke encephalopathy, and Korsakoff syndrome if left untreated.
	• Strokes mostly occur in the peripartum period.
	• Coagulopathy contributes to the genesis of both arterial and venous stroke.
	• There is an overlap between the hormonal changes and interaction with vasoactive agents in the development of preeclampsia, posterior reversible encephalopathy syndrome, and reversible cerebral vasoconstriction syndrome.

Wernicke encephalopathy and Korsakoff syndrome. Central nervous system complications during pregnancy have multiple causes. Physiologic changes occurring during pregnancy include a relative hypercoagulable state, hormonal changes, and shifts in vascular volume.

Nausea and vomiting occur in approximately 70% of pregnant women. The more severe form, hyperemesis gravidarum, may affect 0.3% to 10.8% of pregnancies and leads to depletion of thiamine, a coenzyme essential for glucose metabolism. Etiology has a placental component by implicating common variants in genes encoding placental proteins and hormone receptors (50).

Thiamine deficiency triggers, particularly in Europeans, Wernicke encephalopathy and polyneuropathy or dry beriberi (18). This results in lactic acidosis and necrosis in the medial thalami, mammillary bodies, periaqueductal and paraventricular areas, locus coeruleus, cranial nerve nuclei, and superior cerebellar vermis (134).

The human body stores approximately 30 mg of thiamine and requires 1 to 2 mg of thiamine daily for the oxidative metabolism. The daily needs are increased by alcohol consumption (136). Moreover, the thiamine level may decrease in pregnant women despite multivitamin supplementation (10). Wernicke syndrome may be accelerated by prolonged administration of glucose infusion without thiamine (147).

A genetic susceptibility to develop thiamine deficiency on a diet limited in thiamine was described (123). Multiple humoral factors, from growth differentiation factor 15, insulin-like growth factor binding protein 7, glial cell line-derived neurogenic factor family receptor alpha-like receptor, to the progesterone receptor play a role in etiology of hyperemesis gravidarum (47).

Ischemic stroke. In pregnant women, ischemic stroke may be caused by the conditions unique to pregnancy and by the cerebrovascular risk factors present in the nonpregnant population.

The risk factors associated with pregnancy include peripartum cardiomyopathy, cerebral angiopathy, trophoblastic disease, preeclampsia, and eclampsia. A single-center retrospective study among women with pregnancy-associated stroke had fewer vascular risk factors. Most strokes occurred postpartum and were caused by cerebral venous thrombosis and reversible vasoconstriction syndrome (110).

Arterial occlusion caused by cardioembolism, arterial disease, and hematologic abnormalities is the major cause of ischemic stroke in pregnancy (40). The risk factors for stroke were age of 35 years and older, postpartum infection (odds ratio [OR] 25.0), African American race (OR 1.5), migraine (OR 16.9), thrombophilia (OR 16.0), systemic lupus erythematosus (OR 15.2), heart disease (OR 13.2), sickle cell disease (OR 9.1), hypertension (OR 6.1), preeclampsia and gestational hypertension (OR 4.4), postpartum hemorrhage (OR 1.8), transfusion (OR 10.3), and thrombocytopenia (OR 6.0) (77).

A systematic review of the literature from 1990 to 2022 found nine observational studies, of which eight were eligible for narrative synthesis. Of these, four studies that evaluated preeclampsia found a significant risk of atrial fibrillation. However, these studies were small and suffered from significant statistical heterogeneity (02).

Atherosclerosis accounts for 25% of stroke cases during pregnancy. Pregnancy may aggravate preexisting cardiac abnormalities (eg, valvular disease) or may cause new abnormalities (eg, peripartum cardiomyopathy). Arterial dissection, moyamoya, and Takayasu arteritis may be exacerbated by pregnancy. Rarely, stroke etiology includes air, fat, and amniotic fluid emboli (87). Retrospective analysis of 12 papers including 270 pregnant women with moyamoya disease has not detected an increased risk of stroke during pregnancy (54).

Inherited thrombophilias are associated with venous thromboses during pregnancy (59). Pregnancy is a hypercoagulable state. Increased levels of factors I, II, VII, VIII, IX, and XII and decreased levels of protein S and C have been documented. Moreover, the thrombolytic pathway is inhibited (20). Acquired procoagulant conditions include disseminated intravascular coagulation, sickle cell disease, thrombotic thrombocytopenic purpura, and antiphospholipid antibodies (138; 62). Clinical risk factors for peripartum and postpartum strokes include hypertension, cesarean delivery, and electrolyte and acid-base disorders (93).

Intracerebral hemorrhage. The main causes of intracerebral hemorrhage are hypertension, preeclampsia, or venous thrombosis. Congenital vascular abnormalities, such as aneurysms and arteriovenous malformations, can also cause intracerebral hemorrhage.

Cerebral venous sinus thrombosis (CVST). Venous occlusion is associated with dehydration, infection, and hyperviscosity and is often encountered during pregnancy. Antithrombin III deficiency, protein S and C deficiencies, and paroxysmal nocturnal hemoglobinuria are associated with venous infarction (40). Additionally, genetic mutations in the prothrombin, factor V Leiden, and methylenetetrahydrofolate reductase genes increase the risk of venous thromboembolism (59).

Preeclampsia and eclampsia. The mechanism of preeclampsia is complex and involves uterine vascular tone dysregulation due to endocrine dysfunction, immune system activation, and blood-brain barrier dissolution. Lately, genetic regulation has drawn more attention.

Preeclampsia and eclampsia result in loss of cerebral blood flow autoregulation, hyperperfusion, and edema (28). The increase in progesterone, human chorionic gonadotropin, and relaxin affect the cerebral vasculature (37). Additionally, excessive release of antiangiogenic factors by placenta like the soluble fms-like tyrosine kinase 1 and soluble endoglin was noted. This, coupled with reduced levels of proangiogenic factors like placental growth factor and vascular endothelial growth factor A, may explain the cerebrovascular manifestations (46). Other vasoactive agents involved in preeclampsia include nitric oxide, prostacyclin, thromboxane A₂, endothelin-1, and angiotensin II (60).

Alterations of the neutrophils, macrophages, lymphocytes, natural killer cells, inflammatory cytokines, and anti-angiotensin II type 1 receptor autoantibodies were described in association with preeclampsia (35). Neuroinflammation plays an important role, too. Women with preeclampsia have increased CSF levels of interleukin 6 and 8. Additionally, eclampsia is associated with an increased level of tumor necrosis factor alpha (16).

The blood-brain-barrier (BBB) permeability is also affected. The plasma concentrations of neuronal injury like neurofilament light (NfL), tau protein, neuron-specific enolase (NSE), and S100B were higher in women with preeclampsia than in women with normal pregnancies (55). In women with preeclampsia, neuron-specific enolase and S100B elevation persists at 1 year following delivery (15).

Maternal DNA analysis of 20,064 cases of preeclampsia and 11,027 cases of gestational hypertension found 18 loci associated with these two conditions (74). These loci underscore the role of trophoblast and vascular development, immune response, natriuretic peptide, and kidney function. A genome-wide association study of 16,743 women with prior preeclampsia and 15,200 with preeclampsia or other maternal hypertension during pregnancy found 19 loci related to blood pressure traits, renal function, placental development, remodeling of the uterine spiral arteries, and proteostasis in pregnancy serum (140). MicroRNAs are small molecules that regulate gene expression at the post-transcriptional level (71). Next generation sequencing revealed multiple alterations in microRNA expression that were associated with preeclampsia (107). These alterations have been proposed as potential markers for the diagnosis and monitoring of preeclampsia (131).

Posterior reversible leukoencephalopathy syndrome (PRES). This syndrome was observed mostly in patients with renal insufficiency, hypertension, or immunosuppression (72). The main pathogenic hypotheses are disturbance of autoregulation in cases of hypertension and endothelial dysfunction and blood-barrier disruption in cases of toxic agents. The predominantly posterior location may be explained by the less robust sympathetic innervation of the posterior circulation and a higher susceptibility for edema in the occipital lobes (58).

Reversible cerebral vasoconstriction syndrome (RCVS). Although the mechanism of RCVS is still unknown (127), the nature of the precipitating factors suggests excessive vasoconstriction triggered by cannabis, selective serotonin reuptake inhibitors, nasal decongestants, alcohol binging, steroids, ergots, triptans, cocaine, nicotine patches, noradrenergic and epinephrine, interferon alpha, cyclosporine, and sulprostone (33). There is an overlap between preeclampsia, RCVS, PRES, primary thunderclap headache, takotsubo cardiomyopathy, and transient global amnesia, suggesting some common pathogenic mechanisms (133; 141; 94; 127).

Epidemiology

	• Hyperemesis gravidarum is the most common cause of nonalcoholic Wernicke encephalopathy.
	• Insufficient treatment of Wernicke encephalopathy leads to Korsakoff syndrome.
	• The risk of both ischemic and hemorrhagic stroke is lower in prepartum women but increases up to the 12 weeks.

Wernicke encephalopathy and Korsakoff syndrome. Out of 585 cases on nonalcoholic cases of Wernicke encephalopathy, most were due to hyperemesis gravidarum (177), cancer (129), and hunger strike (119) (114). Wernicke encephalopathy is diagnosed postmortem in up to 80% of cases (68). Approximately 80% of untreated or incompletely treated survivors with a history of alcohol related Wernicke encephalopathy develop Korsakoff syndrome characterized by severe memory impairment (144).

Ischemic stroke. Although rare, peripartum stroke was three times more frequent than in a young population of European descent in a study by Harmsen (67). Between 1955 and 1979, the likelihood of pregnancy-related stroke was 13 times higher than in nonpregnant women of a similar age (151). In New York State, the risk of stroke associated with pregnancy was increased in women younger than 35 years of age, but not in older women (108).

In the U.S., data from a nationwide sample found that stroke incidence was 34.2 per 100,000 deliveries (77). In England, an open-cohort study revealed an increased incidence rate of first ischemic and hemorrhagic stroke, both in peripartum and early postpartum. The incidence rate of stroke was 25.0 per 100,000 person-years outside pregnancy (11). A systematic review and meta-analysis that included 11 studies found that stroke affects 30 out of 100,000 pregnancies (132).

The stroke risk varies with the pregnancy stage. The relative risk of ischemic stroke adjusted for age and race was 0.7 during pregnancy but increased to 8.7 postpartum up to 6 weeks (86).

Discharge data from nonfederal emergency departments and acute care hospitals in California show a modestly increased risk of thrombotic events (stroke, myocardial infarction, or venous thromboembolism) between the seventh and twelfth week postpartum, but not beyond (80). In England, the rate was lower antepartum, 10.7 per 100,000 person-years, but increased 3-fold within 6 weeks to 47.1 per 100,000 person-years, and up to 9-fold to 161.1 per 100,000 person-years within 12 weeks from delivery (11).

The risk of recurrent strokes in subsequent pregnancies was less than 1% at 1 year and 2.3% at 5 years (92). There were 1.4 deaths per 100,000 deliveries (77).

Intraparenchymal and subarachnoid hemorrhage. The incidence rate of intracerebral hemorrhage is 3.5 to 4.6 per 100,000 deliveries. The adjusted relative risk was 2.5 during pregnancy, but it increased to 28.3 in the postpartum period. Overall, for both ischemic and hemorrhagic stroke during pregnancy and peripartum period, the adjusted relative risk was 2.4. The attributable, or excess, risk was 8.1 strokes per 100,000 pregnancies (86).

Subarachnoid hemorrhage occurs in 1 of 10,000 pregnancies but is five times more common in pregnant versus nonpregnant women (150).

Cerebral venous sinus thrombosis (CVST). A pooled analysis of 13 studies showed that the risk of pregnancy-related venous thrombosis and venous thromboembolism were low, 0.9% and 0.27%, respectively (06). Cerebral venous sinus thrombosis occurred in 10 to 20 per 100,000 births in North America and Europe but in up to 200 to 500 per 100,000 births in India. Most cases occurred during the second or third week postpartum (40; 93). The recurrence of cerebral venous thrombosis is 80-fold higher (0.9%) than the risk in the general population (06).

Pregnancy-related hypertensive disease. The incidence of gestational hypertension/preeclampsia is approximately 6% to 8% in the United States. The rate of preeclampsia is 2% to 7% in healthy nulliparous women; 14% in women with twin gestation; and 18% in women with prior preeclampsia (125). There appears to be a racial predisposition; 5% to 10% of whites and 15% to 20% of blacks are at risk. Other high-risk groups include new paternity, multiparous women older than 35 years of age with extrauterine pregnancy, hydatidiform mole, or multiple pregnancies (126; 81; 148). The incidence of eclampsia was 2.7 cases per 10,000 births in a population-based epidemiologic study in the United Kingdom in 2005, a nearly 50% reduction compared to data from 1992 (88).

Posterior reversible leukoencephalopathy (PRES). In the general population, the incidence is unknown. However, the incidence is 0.8% in end-stage renal disease, approximately 0.7% in systemic lupus erythematosus, and 0.5% in solid-organ transplantation survivors, but up to 98.0% among those with preeclampsia or eclampsia (58).

Hemolysis, elevated liver function, and low platelets syndrome (HELLP). HELLP syndrome occurs in 0.5% to 0.9% of all pregnancies and in 10% to 20% of those with severe preeclampsia. Most cases (70%) occur between 27 and 37 weeks and the remainder within 48 hours postpartum (66).

Prevention

	• Thiamine should be given to any patient at risk of Wernicke encephalopathy.
	• Hypoglycemia may be corrected urgently before thiamine is given but must be followed by thiamine.
	• Korsakoff syndrome responds little to thiamine once it has developed.
	• Aspirin in small dose helps prevent ischemic stroke.
	• Low molecular weight heparin prevents venous thromboembolism.
	• Warfarin is used for metallic valves after the thirteenth week.
	• Pregnancy may be continued to term after the discovery of unruptured aneurysms or arteriovenous malformations.

Wernicke encephalopathy. Wernicke encephalopathy prevention consists of intravenous thiamine given to patients at risk. However, if urgently needed, glucose may be given before thiamine (64). In the absence of clinical trial data, urgent thiamine supplementation during or after glucose administration is recommended (121). Prompt administration of intravenous thiamine may also prevent Korsakoff syndrome, which responds little once developed. Intramuscular thiamine 250 mg should be administered daily to patients with poor nutritional status (135).

Ischemic stroke. Prevention of stroke during pregnancy should address the usual risk factors, in particular smoking.

Antiplatelets. For low risk of stroke, low-dose aspirin is recommended. In retrospective studies, aspirin was associated with gastroschisis during the first trimester (91). However, teratogenicity was not confirmed by prospective studies (13). Another concern is premature closure of the fetal ductus arteriosus and maternal or fetal hemorrhage. During the second and third trimesters, aspirin 150 mg or lower daily is safe (76).

Anticoagulation. Subcutaneous unfractionated heparin (UFH) or low molecular weight heparin (LMWH) is recommended for prevention and treatment of venous thromboembolism and of stroke in pregnant women with thrombophilia. Heparins do not cross the placenta and are not associated with teratogenicity or increased risk of fetal hemorrhage.

Low molecular weight heparin has a lower risk of osteoporosis and thrombocytopenia compared to unfractionated heparin (32). Low molecular weight heparin can be administered throughout pregnancy except for a minimum of 24 hours before the expected neuraxial anesthesia, induction of delivery, or C-section.

Warfarin crosses the placenta, is teratogenic during the first trimester, and increases the risk of fetal hemorrhage. Its use is limited to very high-risk cases, such as mechanical heart valve, or when the safety or efficacy of heparin is of concern. A discussion about the risks, benefits, and patient’s concerns is very important.

Patients with mechanical valves may benefit from one of the following regimens:

(a) Unfractionated heparin given subcutaneously every 12 hours and adjusted to keep mid-interval PTT at least twice the control level.

(b) Low molecular weight heparin adjusted to maintain the manufacturer’s peak anti-Xa heparin level 4 hours after the injection.

(c) Metallic mitral valve with higher risk for thrombosis, or additional history of thromboembolism, may benefit from unfractionated heparin or low molecular weight heparin until the thirteenth week, after which warfarin replaces heparin. Shortly before delivery, heparin can be resumed. If the fetal risk is deemed more concerning than valve thrombosis, heparin may be used instead of warfarin. Very high-risk patients may benefit from the addition of 75 to 100 mg of aspirin.

Women requiring long-term anticoagulation for other indications should be switched as soon as pregnancy is diagnosed to dose adjusted or 75% of therapeutic low molecular weight heparin for the duration of pregnancy.

The newer oral anticoagulants, such as direct thrombin inhibitors (eg, dabigatran) or anti-Xa (eg, rivaroxaban, apixaban) should be avoided (13).

Cerebral venous sinus thrombosis (CVST). The risk of recurrent CVST during a subsequent pregnancy is low. In a follow-up study of 112 women with a median follow-up of 14 years, 3 out of 82 new pregnancies experienced a venous thrombotic event, one of which was CVST (34). Nevertheless, low molecular weight heparin is recommended for women with a history of CVST (51).

Intraparenchymal hemorrhage. Pregnancy and puerperium do not increase the risk of hemorrhage in women with cavernous hemangioma (79) or aneurysm (137; 85). This suggests that pregnancy is not contraindicated or needs to be terminated when an incidental lesion is found. Unruptured arteriovenous malformations did not tend to bleed in one study (99) but bled more often in another (117). This conflicting data may reflect outcomes in different populations.

Subarachnoid hemorrhage. Current smoking and hypertension were associated with higher odds of being admitted with aneurysmal subarachnoid hemorrhage compared to treatment for unruptured aneurysm (146). Prevention of subarachnoid hemorrhage includes treatment of hypertension, avoidance of alcohol and tobacco, and a diet rich in fiber. Patients who had subarachnoid hemorrhage or whose first-degree relatives had subarachnoid bleeding should be noninvasively screened for undiagnosed or late regrowth of an aneurysm. After securing an aneurysm by clipping or coiling, follow-up imaging is performed to detect remnants or recurrence of an aneurysm that may require further management (73).

Preeclampsia and eclampsia. Screening for preeclampsia is recommended throughout pregnancy by monitoring the blood pressure (142).

Low dose aspirin is recommended throughout pregnancy starting from the second trimester (13). The number needed to treat (NNT) to prevent one case of eclampsia was 68 overall, though by separating out just the high-risk women, the NNT dropped to 18 (44).

Magnesium sulfate is superior to placebo or phenytoin at preventing seizures in women with preeclampsia (101; 29; 103). In a comparison study of women with severe preeclampsia, magnesium sulfate was more effective for seizure prophylaxis than nimodipine (14). The role of prophylactic magnesium sulfate in mild preeclampsia remains unclear (100; 125).

Differential diagnosis

Associated or underlying disorders

	• Malnutrition or prolonged vomiting suggest Wernicke encephalopathy.
	• Focal neurologic symptoms suggest ischemic or hemorrhagic stroke, tumor, abscess, or encephalitis.
	• Altered mental status should prompt exclusion of top of the basilar syndrome, encephalitis, Behcet disease, Miller-Fischer syndrome, Creutzfeldt-Jakob disease, and toxic-metabolic states.
	• Preeclampsia should be differentiated from thrombocytopenic thrombotic purpura, hemolytic uremic syndrome, and pheochromocytoma.
	• Eclampsia differential diagnosis includes epilepsy, metabolic disorders, and pheochromocytoma.

Considerable overlap exists between the clinical presentations of the various central nervous system complications described. Focal neurologic symptoms should prompt investigation for cerebrovascular disease (particularly venous thrombosis, arterial occlusion, or embolism) and intracerebral or subarachnoid hemorrhage. Space-occupying lesions such as tumors and infection from brain abscess, meningitis, and encephalitis can also cause symptoms.

The association of ataxia, ophthalmoparesis, and altered mental status in the context of malnutrition or prolonged vomiting suggests Wernicke encephalopathy. However, not all symptoms are present and often alcohol abuse is suspected.

Other causes for acute encephalopathy should be excluded. Among these are stroke (top of the basilar syndrome), paraneoplastic encephalitis, Bickerstaff encephalitis, Bechet disease, ventriculoencephalitis, Miller-Fischer syndrome, Leigh disease, variant Creutzfeldt-Jakob disease, as well as various toxic metabolic states (123).

Transient focal neurologic symptoms during pregnancy present a diagnostic challenge. In a case control series of patients with transient focal dysphasia, hemisensory loss or hemiparesis in the absence of migraine, recurrent thromboembolism, or known cerebral vascular disease, only 1 of the 14 patients had infarction on MRI DWI (98). Nine of the 14 patients had headaches of variable severity. None had abnormal MRV, echocardiogram, or carotid duplex ultrasonography, and none had a hypercoagulable state. No patients had recurrence of focal neurologic symptoms over a mean period of 12 months, although four patients developed recurrent migraine headaches.

Eclampsia may be difficult to diagnose when seizures and coma are preceded by minimal preeclamptic symptoms. Epilepsy must always be considered in the diagnosis of convulsions during pregnancy. Metabolic disorders like hypoglycemia, hypocalcemia, and water intoxication can also induce seizures and coma. Pheochromocytoma associated with fluctuating hypertension and hypertensive encephalopathy should also be excluded (81).

Preeclampsia with hematologic abnormalities should be differentiated from thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Thrombotic thrombocytopenic purpura is an idiopathic severe multisystem disorder, often precipitated by pregnancy. Clinical features include fever, hemolytic anemia, thrombocytopenic purpura, renal disease, and neurologic symptoms of stupor, coma, and convulsions (49). Hemolytic uremic syndrome is considered part of the same spectrum of disease, with similar clinical features. Both disorders are managed with plasma therapy and corticosteroids (149).

Diagnostic workup

	• Wernicke encephalopathy should be suspected in any patient with insufficient food intake or excessive vomiting.
	• Stroke evaluation should include the etiologies in young patients.
	• Shielded CT scans are required in pregnant patients.
	• CT is sensitive enough to detect subarachnoid hemorrhage in almost all cases.
	• The blood tests for preeclampsia, eclampsia, and HELLP should include electrolytes, hemogram, hemolysis, and liver function.

Wernicke encephalopathy. The diagnosis of Wernicke encephalopathy is mainly based on clinical features. Thiamine level or red blood cell transketolase activity may confirm the initial suspicion (123). Cerebral MRI may reveal necrotic lesions in the regions associated with Wernicke encephalopathy: medial thalami, mammillary bodies, periaqueductal and paraventricular areas, locus coeruleus, cranial nerve nuclei, and superior cerebellar vermis (90; 09).

Acute ischemic stroke. Acute ischemic stroke requires evaluation for etiology in the young person (115). Complete blood count, sedimentation rate, syphilis screen, and coagulation studies should be performed. Testing for hypercoagulable states includes protein C and protein S levels, antithrombin III levels, and Russell viper venom test for antiphospholipid antibodies. Genetic screening includes Factor V Leiden, prothrombin gene, and methylenetetrahydrofolate reductase mutations. Human chorionic gonadotropin level can be useful if choriocarcinoma is a suspected cause of hemorrhagic stroke (40).

CT scan with proper shielding can rapidly exclude intracerebral hemorrhage or evaluate for edema. MRI can assess focal brain pathology, acute ischemia, and cerebral edema. CT or MR angiography may demonstrate arterial stenosis, vasospasm, or occlusion. MR venography can detect cerebral venous thrombosis. If contrast agents are used, adequate hydration is recommended. CT perfusion can quantify the penumbra core mismatch and determine eligibility for thrombectomy in selected patients. Cardioembolism can be detected with EKG, loop recorder, and echocardiogram.

Subarachnoid hemorrhage. Lumbar puncture is essential for excluding subarachnoid hemorrhage but should be avoided if venous thrombosis with increased intracranial pressure is suspected (38). Advances in CT technology have improved the sensitivity for subarachnoid hemorrhage to 0.987 and specificity to 0.999 and may rule out hemorrhage within 6 hours from onset, without the need for lumbar puncture (41). Conventional cerebral angiography is useful for diagnosis of aneurysms and vasculitides.

Preeclampsia and eclampsia. If preeclampsia or eclampsia is suspected clinically, laboratory evaluation should include peripheral smear, hemolysis studies, and kidney and liver function tests. Reversible vasogenic edema resembling posterior reversible encephalopathy syndrome was demonstrated on brain CT and MRI (72). In a retrospective study of 49 women with preeclampsia and eclampsia with neurologic symptoms, 90% of patients with eclampsia and 20% of those with preeclampsia had MRI changes suggestive of posterior reversible encephalopathy syndrome (104).

Reversible cerebral vasoconstriction syndrome (RCVS). Initially, the brain CT is normal. Later, brain MRI may reveal convexity subarachnoid hemorrhage, lobar hemorrhages, and hyperintensities located in arterial "watershed" territories and reversible edema in up to 50% of patients (127).

Hemolysis, elevated liver function, and low platelets syndrome (HELLP). HELLP should be differentiated from acute fatty liver of pregnancy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura, which may present with similar clinical and laboratory findings (12). In addition to hemolysis, diagnosis of HELLP requires peripheral smear, elevated indirect bilirubin level, decreased haptoglobin level, and thrombocytopenia (124). In less than one third of patients, the diagnosis of HELLP syndrome is made based on specific laboratory abnormalities (81).

Management

	• Thiamine is best administered intravenously in hyperemesis gravidarum.
	• Antiemetics help reduce vomiting in hyperemesis gravidarum.
	• Alteplase was used off-label in pregnant women and is reasonable to use if benefits outweigh the risks.
	• Large arterial occlusion is more likely to be treated successfully with endovascular therapy.
	• The benefits and risks of treatments in pregnant women should be thoroughly discussed with the patients.
	• Vaginal delivery is safe after aneurysm repair.
	• If the aneurysm is unsecured, cesarean section is recommended.
	• Preeclampsia and eclampsia are best treated by delivery.
	• Seizures respond better to magnesium sulfate intravenously.

Wernicke encephalopathy responds best to intravenous thiamine (68). Although no randomized trials are available, different regimens have been used: 500 mg intravenous over 30 minutes two to three times a day for 2 to 3 days or up to 6 days if no response is seen initially. If this regimen is effective, 250 mg intravenous or intramuscular is given daily for 5 days or until clinical improvement ceases. Moderate to severe nausea respond to pyridoxine-doxylamine, promethazine, metoclopramide, and ondansetron (105).

Ischemic stroke. Pregnant women were excluded from the randomized trials of stroke treatment. Alteplase or tPA is category C, does not cross placenta, and is not associated with animal teratogenicity. Off-label use of thrombolytics in 11 pregnancies (five intravenous and six intraarterial) resulted in one fatal intracerebral hemorrhage and three extracranial hematomas. Six fetuses were lost to abortion, three of which were elective (04). Analysis of Get With The Guidelines-Stroke registry data shows that nonpregnant women who received rt-PA had similar outcomes (96). It is reasonable to treat moderate or severe stroke with tPA if the benefit seems to outweigh the increased risk of uterine hemorrhage (118).

In the clinical trials that enrolled nonpregnant patients, large vessel occlusion is treated more effectively by endovascular treatment than intravenous rtPA alone (17; 25; 61; 78; 120). Perfusion imaging helps selection for endovascular intervention of patients presenting between 6 to 16 hours from the last time they were known to be normal (03). Even patients with stroke onset between 6 to 24 hours who exhibit a mismatch between the core delineated by MRI-DWI or CT perfusion and clinical severity may benefit from endovascular intervention (112). As endovascular treatment was not tested specifically in pregnant women, a thorough discussion of the risks and benefits as well as careful shielding are needed (22).

Cerebral venous sinus thrombosis (CVST). There are limited data on the best approach to CVST treatment. However, the consensus is that unfractionated or low molecular weight heparin is reasonable regardless of the presence of hemorrhagic transformation. If neurologic worsening occurs despite anticoagulation, or the mass effect or increased intracranial pressure is refractory to medical measures, surgical decompression or endovascular thrombolytic measures may be attempted (119).

Subarachnoid hemorrhage. Treatment of vascular malformations during pregnancy should be based on the same neurosurgical principles as in the nonpregnant state. Early aneurysm obliteration, but not the treatment of ruptured arteriovenous malformations, was associated with decreased mortality rate (37).

Labor and delivery do not appear to increase the risk of hemorrhage from arteriovenous malformations or aneurysms. The decision to perform caesarean section should be based on obstetric indications (75). The management of aneurysmal subarachnoid hemorrhage and arteriovenous malformations may require transfer to a specialized medical center (129). Increasingly, aneurysms are treated by endovascular approach, but the outcome is not modified by the treatment modality (84).

The definitive treatment of aneurysmal subarachnoid hemorrhage is obliteration of the aneurysm by coiling or clipping, ideally within 24 hours from onset. If there is a coagulopathy, it should be corrected. Until the aneurysm is secured, the systolic blood pressure should be controlled to prevent rebleeding while maintaining cerebral perfusion. There is no well-defined blood pressure target as this depends on multiple factors, like blood pressure on presentation, brain swelling, hydrocephalus, history of hypertension, or renal dysfunction. During anesthesia, it is important to control blood pressure and normoglycemia. After the ruptured aneurysm is obliterated, vaginal delivery is safe. If the ruptured aneurysm cannot be completely treated initially, partial obliteration and later retreatment may be attempted. Cesarean section is recommended in these patients (73). Surgical repair of the aneurysm immediately after delivery has been successfully performed (150; 39).

Vasospasm and delayed cerebral ischemia may be prevented by administration of oral nimodipine and intravenous fluids. Development of vasospasm is diagnosed with serial transcranial ultrasound, CT angiography, CT perfusion, or continuous EEG. Elevation of blood pressure with maintenance of euvolemia may be used in symptomatic ischemia. However, hemodynamic augmentation and hypervolemia should be avoided. If vasospasm and cerebral ischemia do not respond promptly to hydration, intra-arterial balloon angioplasty combined with a vasodilator may be needed to prevent stroke.

Seizures are diagnosed clinically and by EEG monitoring in patients with depressed or fluctuating consciousness. New-onset seizures should be treated. Prophylaxis is usually limited to 7 days. Longer-term prophylactic antiepileptic medication should be avoided but considered in patients at high risk, including rupture of middle cerebral artery aneurysm, high-grade subarachnoid hemorrhage, hydrocephalus, intraparenchymal hemorrhage, and cortical infarction (73).

Preeclampsia and eclampsia. The definitive treatment of preeclampsia and eclampsia is delivery (148). Control of hypertension, seizures, and management of cerebral edema may be needed. In severe cases, transfer to a neurointensive care unit, intubation, and hyperventilation may be necessary to manage cerebral edema. Mannitol should be used cautiously to avoid placental dehydration and pulmonary edema (81).

The management goal is prevention of cerebral and cardiovascular complications by lowering mean arterial pressure by 20% to 25%. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are contraindicated during pregnancy. In a meta-analysis of antihypertensive therapy, early treatment decreased the frequency of hypertensive crisis and of neonatal complications. Labetalol and nifedipine were more effective and safer than hydralazine. Nimodipine, diazoxide, ketanserin, and magnesium sulphate are best avoided for hypertension treatment (45). After delivery, initiation of blood pressure control at a lower threshold (140/90 mmHg vs. 150/95 mmHg) did not seem to decrease maternal morbidity (01).

Seizures respond best to magnesium sulfate (29; 43; 103). Potential mechanisms include magnesium-induced vasodilation, protection of the blood-brain barrier resulting in decreased cerebral edema, or anticonvulsant activity mediated through NMDA receptor antagonism (48). Toxicity of magnesium includes profound weakness, hypoventilation, tocolysis, anesthetic complications, and neonatal weakness (39). Magnesium sulfate should be administered for prevention of seizures, with close monitoring of toxicity and serum levels of 4.2 to 8.4 mg/dL (48).

Posterior reversible leukoencephalopathy syndrome (PRES). Management of PRES is best undertaken in the neurologic ICU. The mainstay of treatment consists of removal of the provoking agent, treatment of high blood pressure, seizures, cerebral edema, and encephalopathy. Urgent decrease of systolic blood pressure up to 25% is followed by normalization of blood pressure within 24 to 48 hours. Nicardipine, clevidipine, or labetalol intravenously are the preferred agents. Seizures should be treated with a benzodiazepine followed by a longer acting antiepileptic (58).

Reversible cerebral vasoconstriction syndrome (RCVS). Once diagnosed, avoid the triggering factors and glucocorticoids. Vasodilation with oral calcium-channel blockers is used for reversal of the arterial spasm. In refractory cases, intra-arterial vasodilators can be used (127). In case reports, Cesarean section with general or epidural anesthesia resolved the headache promptly (36; 154).

Hemolysis, elevated liver function, and low platelets syndrome (HELLP). Conservative treatment is controversial and may be attempted in partial cases before 34 weeks’ gestation. Between 24 and 34 weeks, corticosteroid therapy is needed for fetal lung maturation (66). Delivery is indicated after 34 weeks or if the clinical condition of the mother or fetus deteriorates. A Cochrane review did not support the use of corticosteroids in HELLP syndrome (153).

References

01: Aderibigbe OA, Hackney DN, Ranzini AC, Lappen JR. Tight vs liberal control of mild postpartum hypertension: a randomized controlled trial. Am J Obstet Gynecol MFM 2023;5(2):100818. PMID 36402355
02: Al Bahhawi T, Aqeeli A, Harrison SL, et al. Pregnancy-related complications and incidence of atrial fibrillation: a systematic review. J Clin Med 2023;12(4):1316. PMID 36835851
03: Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018;378(8):708-18. PMID 29364767
04: Aleu A, Mellado P, Lichy C, Kohrmann M, Schellinger PD. Hemorrhagic complications after off-label thrombolysis for ischemic stroke. Stroke 2007;38(2):417-22. PMID 17185641
05: Allbert JR, Morrison JC. Neurologic diseases in pregnancy. Obstet Gynecol Clin North Am 1992;19(4):765-81. PMID 1484659
06: Aguiar de Sousa D, Canhão P, Ferro JM. Safety of pregnancy after cerebral venous thrombosis: a systematic review. Stroke 2016;47(3):713-8. PMID 26797665
07: Anonymous. Gestational hypertension and preeclampsia: ACOG practice bulletin summary, number 222. Obstet Gynecol 2020;135(6):1492-5. PMID 32443077
08: Arts NJ, Walvoort SJ, Kessels RP. Korsakoff's syndrome: a critical review. Neuropsychiatr Dis Treat 2017;13:2875-90. PMID 29225466
09: Ashraf VV, Prijesh J, Praveenkumar R, Saifudheen K. Wernicke's encephalopathy due to hyperemesis gravidarum: Clinical and magnetic resonance imaging characteristics. J Postgrad Med 2016;62(4):260-3. PMID 27763485
10: Baker H, DeAngelis B, Holland B, Gittens-Williams L, Barrett T Jr. Vitamin profile of 563 gravidas during trimesters of pregnancy. J Am Coll Nutr 2002;21(1):33-7. PMID 11838885
11: Ban L, Sprigg N, Abdul Sultan A, et al. Incidence of first stroke in pregnant and nonpregnant women of childbearing age: a population-based cohort study from England. J Am Heart Assoc 2017;6(4). PMID 28432074
12: Barton JR, Sibai BM. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol 2004;31(4):807-33, vii. PMID 15519429
13: Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e691S-736S. PMID 22315276
14: Belfort MA, Anthony J, Saade GR, Allen JC Jr. Nimodipine Study Group. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003;348(4):304-11. PMID 12540643
15: Bergman L, Åkerud H, Wikström AK, et al. Cerebral biomarkers in women with preeclampsia are still elevated 1 year postpartum. Am J Hypertens 2016;29(12):1374-9. PMID 27653032
16: Bergman L, Hastie R, Zetterberg H, et al. Evidence of neuroinflammation and blood-brain barrier disruption in women with preeclampsia and eclampsia. Cells 2021;10(11):3045. PMID 34831266
17: Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372(1):11-20. PMID 25517348
18: Blass JP, Gibson GE. Abnormality of a thiamine requiring enzyme in patients with Wernicke-Korsakoff Syndrome. N Engl J Med 1977;297(25):1367-70. PMID 927453
19: Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol 2007;6(2):162-70. PMID 17239803
20: Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003;16(2):153-68. PMID 12763484
21: Brewer J, Owens MY, Wallace K, et al. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am J Obstet Gynecol 2013;208(6):468.e1-6. PMID 23395926
22: Broderick JP. Should intravenous thrombolysis be considered the first option in pregnant women? Stroke 2013;44(3):866-7. PMID 23391771
23: Brown DW, Dueker N, Jamieson DJ, et al. Preeclampsia and the risk of ischemic stroke among young women: results from the Stroke Prevention in Young Women Study. Stroke 2006;37(4):1055-9. PMID 16484606
24: Burton TM, Bushnell CD. Reversible cerebral vasoconstriction syndrome. Stroke 2019;50(8):2253-8. PMID 31272323
25: Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015;372(11):1009-18. PMID 25671797
26: Cano A, Valero MV, Llorens J, Santonja JJ. Fulminant subarachnoidal hemorrhage and coma subsequent to sudden-presenting hypertension. Eur J Obstet Gynecol Reprod Biol 1992;47(1):80-2. PMID 1426516
27: Chang J, Elam-Evans LD, Berg CJ, et al. Pregnancy-related mortality surveillance--United States, 1991--1999. MMWR Surveill Summ 2003;52(2):1-8. PMID 12825542
28: Cipolla MJ. Cerebrovascular function in pregnancy and eclampsia. Hypertension 2007;50(1):14-24. PMID 17548723
29: Coetzee EJ, Dommisse J, Anthony J. A randomized controlled trial of intravenous magnesium sulfate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol 1998;105:300-3. PMID 9532990
30: Coutinho JM, Ferro JM, Canhao P, et al. Cerebral venous and sinus thrombosis in women. Stroke 2009;40(7):2356-61. PMID 19478226
31: Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol 2015;125(1):5-12. PMID 25560097
32: Cronin CA, Weisman CJ, Llinas RH. Stroke treatment: beyond the three-hour window and in the pregnant patient. Ann NY Acad Sci 2008;1142:159-78. PMID 18990126
33: de Boysson H, Parienti JJ, Mawet J, et al. Primary angiitis of the CNS and reversible cerebral vasoconstriction syndrome: a comparative study. Neurology 2018;91(16):e1468-78. PMID 30232250
34: de Sousa DA, Canhao P, Crassard I, et al. Safety of pregnancy after cerebral venous thrombosis: results of the ISCVT (International Study on Cerebral Vein and Dural Sinus Thrombosis)-2 PREGNANCY Study. Stroke 2017;48(11):3130-3. PMID 28974635
35: Deer E, Herrock O, Campbell N, et al. The role of immune cells and mediators in preeclampsia. Nat Rev Nephrol 2023;19(4):257-70. PMID 36635411
36: Descamps R, Envain F, Kuchcinski G, Clouqueur E, Henon H, Gonzalez-Estevez M. Cesarean section under general anesthesia for antepartum reversible cerebral vasoconstriction syndrome: a case report. J Obstet Gynaecol Res 2019;45(12):2461-5. PMID 31463978
37: Dias MS, Sekhar LN. Intracranial hemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery 1990;27(6):855-65; discussion 865-6. PMID 2274125
38: Donaldson JO. Cerebrovascular disease. In: Neurology of pregnancy. 2nd edition. London: WB Saunders Company, 1989a:137-77.
39: Donaldson JO. Neurologic emergencies in pregnancy. Obstet Gynecol Clin North Am 1991;18(2):199-212. PMID 1945251
40: Donaldson JO, Lee NS. Arterial and venous stroke associated with pregnancy. Neurol Clin 1994;12(3):583-99. PMID 7990792
41: Dubosh NM, Bellolio MF, Rabinstein AA, Edlow JA. Sensitivity of early brain computed tomography to exclude aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Stroke 2016;47(3):750-5. PMID 26797666
42: Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007;130(Pt 12):3091-101. PMID 18025032
43: Duley L, Henderson-Smart D. Magnesium sulfate versus phenytoin for eclampsia. Cochrane Database Syst Rev 2000a;2:CD000128. PMID 10796146
44: Duley L, Henderson-Smart D, Knight M, King J. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. BMJ 2001;322(7282):329-33. PMID 11159655
45: Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2013;2013(7):CD001449. PMID 23900968
46: Dymara-Konopka W, Laskowska M, Błażewicz A. Angiogenic imbalance as a contributor of preeclampsia. Curr Pharm Biotechnol 2018;19(10):797-815. PMID 30255753
47: Erick M. Gestational malnutrition, hyperemesis gravidarum, and Wernicke's encephalopathy: What is missing? Nutr Clin Pract 2022;37(6):1273-90. PMID 36250744
48: Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke 2009;40(4):1169-75. PMID 19211496
49: Ezra Y, Rose M, Eldor A. Therapy and prevention of thrombotic thrombocytopenic purpura during pregnancy: a clinical study of 16 pregnancies. Am J Hematol 1996;51(1):1-6. PMID 8571931
50: Fejzo MS, Trovik J, Grooten IJ, et al. Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nat Rev Dis Primers 2019;5(1):62. PMID 31515515
51: Ferro JM, Bousser MG, Canhão P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. Eur J Neurol 2017;24(10):1203-13. PMID 28833980
52: Ferro JM, Canhao P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35(3):664-70. PMID 14976332
53: Finelli PF. Postpartum eclampsia and subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 1992;2(3):151-3. PMID 26486713
54: Fluss R, Ligas BA, Chan AW, et al. Moyamoya-related stroke risk during pregnancy: an evidence-based reappraisal. World Neurosurg 2019;129:e582-5. PMID 31176061
55: Friis T, Wikström AK, Acurio J, et al. Cerebral biomarkers and blood-brain barrier integrity in preeclampsia. Cells 2022;11(5):789. PMID 35269411
56: Fugate JE, Wijdicks EFM, Parisi DF, et al. Fulminant postpartum cerebral vasoconstriction syndrome. Arch Neurol 2012;69(1):111-7. PMID 22232351
57: Garcia-Reitboeck P, Al-Memar A. Images in clinical medicine: Reversible cerebral vasoconstriction after preeclampsia. N Engl J Med 2013;369(3):e4. PMID 23863073
58: Geocadin RG. Posterior reversible encephalopathy syndrome. N Engl J Med 2023;388(23):2171-8. PMID 37285527
59: Gerhardt A, Scharf RE, Beckmann MW, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000;342(6):424-5. PMID 10666427
60: Goulopoulou S. Maternal vascular physiology in preeclampsia. Hypertension 2017;70(6):1066-73. PMID 29061723
61: Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372(11):1019-30. PMID 25671798
62: Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999;353:1258-65. PMID 10217099
63: Guglielminotti J, Landau R, Li G. Major neurologic complications associated with postdural puncture headache in obstetrics: a retrospective cohort study. Anesth Analg 2019;129(5):1328-36. PMID 31335402
64: Hack JB, Hoffman RS. Thiamine before glucose to prevent Wernicke encephalopathy: examining the conventional wisdom. JAMA 1998;279(8):583-4. PMID 9486750
65: Haddad B, Barton JR, Livingston JC, Chahine R, Sibai BM. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at ≤28.0 weeks' gestation. Am J Obstet Gynecol 2000;183(6):1475-9. PMID 11120513
66: Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth 2009;9:8. PMID 19245695
67: Harmsen P, Wilhelmsen L, Jacobsson A. Stroke incidence and mortality rates 1987 to 2006 related to secular trends of cardiovascular risk factors in Gothenburg, Sweden. Stroke 2009;40(8):2691-7. PMID 19498188
68: Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry 1986;49(4):341-5. PMID 3701343
69: Harscher S, Witte OW, Möller U, Bloos G, Pfleiderer SO, Terborg C. Cerebral vasospasms with hemodynamic infarctions as a complication of HELLP syndrome [Article in German]. Nervenarzt 2003;74(12):1122-6. PMID 14647914
70: Hashiguchi K, Inamura T, Irita K, et al. Late occurrence of diffuse cerebral swelling after intracerebral hemorrhage in a patient with the HELLP syndrome--case report. Neurol Med Chir (Tokyo) 2001;41(3):144-8. PMID 11372559
71: Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 2012;12(9):613-26. PMID 22898542
72: Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334(8):494-500. PMID 8559202
73: Hoh BL, Ko NU, Amin-Hanjani S, et al. 2023 Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke 2023;54(7):e314-70. PMID 37212182
74: Honigberg MC, Truong B, Khan RR, et al. Polygenic prediction of preeclampsia and gestational hypertension. Nat Med 2023;29(6):1540-9. PMID 37248299
75: Horton JC, Chambers WA, Lyons SL, Adams RD, Kjellberg RN. Pregnancy and the risk of hemorrhage from cerebral arteriovenous malformations. Neurosurgery 1990;27(6):867-71; discussion 871-2. PMID 2274126
76: Imperiale TF, Petrulis AS. A meta-analysis of low dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 1991;266(2):260-4. PMID 1829118
77: James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005;106(3):509-16. PMID 16135580
78: Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015;372(24):2296-306. PMID 25882510
79: Kalani MY, Zabramski JM. Risk for symptomatic hemorrhage of cerebral cavernous malformations during pregnancy. J Neurosurg 2013;118(1):50-5. PMID 23039155
80: Kamel H, Navi BB, Sriram N, Hovsepian DA, Devereux RB, Elkind MS. Risk of a thrombotic event after the 6‐week postpartum period. N Engl J Med 2014;370(14):1307-15. PMID 24524551
81: Kaplan PW, Repke JT. Eclampsia. Neurol Clin 1994;12(3):565-82. PMID 7990791
82: Kashkoush AI, Ma H, Agarwal N, et al. Cerebral venous sinus thrombosis in pregnancy and puerperium: A pooled, systematic review. J Clin Neurosci 2017;39:9-15. PMID 28274514
83: Katz VL, Cefalo RC. Maternal death from carotid artery thrombosis associated with the syndrome of hemolysis, elevated liver function, and low platelets. Am J Perinatol 1989;6(3):360-2. PMID 2730743
84: Khatibi K, Saber H, Patel S, et al. Aneurysmal subarachnoid hemorrhage in pregnancy: national trends of treatment, predictors, and outcomes. PLoS One 2023;18(5):e0285082. PMID 37141265
85: Kim YW, Neal D, Hoh BL. Cerebral aneurysms in pregnancy and delivery: pregnancy and delivery do not increase the risk of aneurysm rupture. Neurosurgery 2013;72(2):143-9. PMID 23147786
86: Kittner SJ, Stern BJ, Feeser BR, et al. Pregnancy and the risk of stroke. N Engl J Med 1996;335(11):768-74. PMID 8703181
87: Knepper LE, Giuliani MJ. Cerebrovascular disease in women. Cardiology 1995;86(4):339-48. PMID 7553709
88: Knight M; UKOSS. Eclampsia in the United Kingdom 2005. BJOG 2007;114(9):1072-8.
89: Koehler PJ. The influence of Carl Wernicke and German neuropsychiatry in: Syllabus: “Masters of Neurology” Neurohistory Course p.1-21. American Academy of Neurology, Toronto, 17-24 April 1999.
90: Kotha VK, De Souza A. Wernicke's encephalopathy following Hyperemesis gravidarum. A report of three cases. Neuroradiol J 2013;26(1):35-40. PMID 23859165
91: Kozer E, Nikfar S, Costei A, Boskovic R, Nulman I, Koren G. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002;187(6):1623-30. PMID 12501074
92: Lamy C, Hamon JB, Coste J, Mas JL. Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. Neurology 2000;55:269-74. PMID 10908903
93: Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000;31:1274-82. PMID 10835444
94: Lee DE, Krishnan A, Collins R. Reversible cerebral vasoconstriction syndrome in the postpartum period: a case report and review of the literature. Int J Gynaecol Obstet 2023;162(3):823-8. PMID 36965125
95: Leffert LR, Clancy CR, Bateman BT, et al. Patient characteristics and outcomes after hemorrhagic stroke in pregnancy. Circ Cardiovasc Qual Outcomes 2015;8(6 Suppl 3):S170-8. PMID 26515206
96: Leffert LR, Clancy CR, Bateman BT, et al. Treatment patterns and short-term outcomes in ischemic stroke in pregnancy or postpartum period. Am J Obstet Gynecol 2016;214(6):723.e1-723.e11. PMID 26709084
97: Legriel S, Schraub O, Azoulay E, et al. Determinants of recovery from severe posterior reversible encephalopathy syndrome. PLoS One 2012;7(9):e44534. PMID 23024751
98: Liberman A, Karussis D, Ben-Hur T, Abramsky O, Leker RR. Natural course and pathogenesis of transient focal neurologic symptoms during pregnancy. Arch Neurol 2008;65(2):218-20. PMID 18268190
99: Liu XJ, Wang S, Zhao YL, et al. Risk of cerebral arteriovenous malformation rupture during pregnancy and puerperium. Neurology 2014;82(20):1798-803. PMID 24759847
100: Livingston JC, Livingston LW, Ramsey R, Mabie BC, Sibai BM. Magnesium sulfate in women with mild pre-eclampsia: A randomized, double blinded, placebo-controlled trial. Obstet Gynecol 2003;101:217-20. PMID 12576241
101: Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995;333(4):201-5. PMID 7791836
102: MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001;97(4):533-8. PMID 11275024
103: Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulfate. The Magpie trial: a randomized placebo-controlled trial. Lancet 2002;359(9321):1877-90. PMID 12057549
104: Mayama M, Uno K, Tano S, et al. Incidence of posterior reversible encephalopathy syndrome in eclamptic and patients with preeclampsia with neurologic symptoms. Am J Obstet Gynecol 2016;215(2):239.e1-5. PMID 26902987
105: McParlin C, O'Donnell A, Robson SC, et al. Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review. JAMA 2016;316(13):1392-401. PMID 27701665
106: Mengi T, Beckmann Y. Wernicke encephalopathy with epileptic seizures during pregnancy. Neurocase 2022;28(2):185-7. PMID 35465832
107: Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet 2010;11(1):31-46. PMID 19997069
108: Miller EC, Gatollari HJ, Too G, et al. Risk of pregnancy-associated stroke across age groups in New York state. JAMA Neurol 2016b;73(12):1461-7. PMID 27775757
109: Miller EC, Leffert L. Stroke in pregnancy: a focused update. Anesth Analg 2020;130(4):1085-96. PMID 31124843
110: Miller EC, Yaghi S, Boehme AK, Willey JZ, Elkind MS, Marshall RS. Mechanisms and outcomes of stroke during pregnancy and the postpartum period: a cross-sectional study. Neurol Clin Pract 2016a;6(1):29-39. PMID 26918201
111: Nishimoto A, Usery J, Winton JC, Twilla J. High-dose parenteral thiamine in treatment of Wernicke's encephalopathy: case series and review of the literature. In Vivo 2017;31(1):121-4. PMID 28064230
112: Nogueira RG, Jadhav AP, Haussen, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018;378(1):11-21. PMID 29129157
113: Oudman E, Winja JW, Oey M, et al. Wernicke’s encephalopathy in hyperemesis gravidarum: a systematic review. Eur J Obstet Gynecol Reprod Biol 2019;236:84-93. PMID 30889425
114: Oudman E, Wijnia JW, Oey MJ, van Dam M, Postma A. Wernicke-Korsakoff syndrome despite no alcohol abuse: a summary of systematic reports. J Neurol Sci 2021;426:117482. PMID 34000679
115: Pathan M, Kittner SJ. Pregnancy and stroke. Curr Neurol Neurosci Rep 2003;3(1):27-31. PMID 12507407
116: Paul BS, Juneja SK, Paul G, Gupta S. Spectrum of neurological complications in HELLP syndrome. Neurol India 2013;61(5):467-71. PMID 24262446
117: Porras JL, Yang W, Philadelphia E, et al. Hemorrhage risk of brain arteriovenous malformations during pregnancy and puerperium in a North American cohort. Stroke 2017;48(6):1507-13. PMID 28487334
118: Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2019;50(12):e344-e418. PMID 31662037
119: Saposnik G, Barinagarrementeria F, Brown RD Jr, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42(4):1158-92. PMID 21293023
120: Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015;372(24):2285-95. PMID 25882376
121: Schabelman E, Kuo D. Glucose before thiamine for Wernicke encephalopathy: a literature review. J Emerg Med 2012;42(4):488-94. PMID 22104258
122: Scott CA, Bewley S, Rudd A, et al. Incidence, risk factors, management, and outcomes of stroke in pregnancy. Obstet Gynecol 2012;120(2 Pt 1):318-24. PMID 22825091
123: Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 2007;6(5):442-55. PMID 17434099
124: Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004;103(5 Pt 1):981-91. PMID 15121574
125: Sibai BM. Diagnosis and management of gestational hypertension and Preeclampsia. Obstet Gynecol 2003;102:181-92. PMID 12850627
126: Sibai BM, Abdella TN, Spinnato JA, Anderson GD. Eclampsia. V. The incidence of nonpreventable eclampsia. Am J Obstet Gynecol 1986;154(3):581-6. PMID 3953703
127: Singhal AB. Reversible cerebral vasoconstriction syndrome: a review of pathogenesis, clinical presentation, and treatment. Int J Stroke 2023;18(10):1151-60. PMID 37246916
128: Singhal AB, Hajj-Ali RA, Topcuoglu MA, et al. Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol 2011;68(8):1005-12. PMID 21482916
129: Sloan MA, Stern BJ. Cerebrovascular Disease in Pregnancy. Curr Treat Options Neurol 2003;5(5):391-407. PMID 12895402
130: Spiegel A, Spiegel DR, McLean A, Monter E, Cronin A, Kamano E. Wernicke’s encephalopathy due to hyperemesis gravidarum masquerading as major depressive disorder: a reminder to assess for at-risk thiamine deficiency states. Prim Care Companion CNS Disord 2022;24(3):21cr03032. PMID 35605258
131: Subramanian A, Weiss D, Nyhan K, Dewan A, Jukic AMZ. Circulating miRNAs in the first trimester and pregnancy complications: a systematic review. Epigenetics 2023;18(1):2152615. PMID 36503407
132: Swartz RH, Cayley ML, Foley N, et al. The incidence of pregnancy-related stroke: A systematic review and meta-analysis. Int J Stroke 2017;12(7):687-97. PMID 28884652
133: Tanaka K, Matsushima M, Matsuzawa Y, et al. Antepartum reversible cerebral vasoconstriction syndrome with pre-eclampsia and reversible posterior leukoencephalopathy. J Obstet Gynaecol Res 2015;41(11):1843-7. PMID 26178813
134: Thomson AD. Mechanisms of vitamin deficiency in chronic alcohol misusers and the development of the Wernicke-Korsakoff syndrome. Alcohol Alcohol Suppl 2000;35(1):2-7. PMID 11304071
135: Thomson AD, Cook CC, Touquet R, Henry JA, Royal College of Physicians, London. The Royal College of Physicians report on alcohol: guidelines for managing Wernicke's encephalopathy in the accident and emergency department. Alcohol Alcohol Suppl 2002;37(6):513-21. PMID 12414541
136: Thomson AD, Guerrini I, Marshall EJ. The evolution and treatment of Korsakoff's syndrome: out of sight, out of mind? Neuropsychol Rev 2012;22(2):81-92. PMID 22569770
137: Tiel Groenestege AT, Rinkel GJ, van der Bom JG, Algra A, Klijn CJ. The risk of aneurysmal subarachnoid hemorrhage during pregnancy, delivery, and the puerperium in the Utrecht population: case-crossover study and standardized incidence ratio estimation. Stroke 2009;40(4):1148-51. PMID 19211489
138: Toglia MR, Weg JG. Venous thromboembolism during pregnancy. N Engl J Med 1996;335(2):108-14. PMID 8649471
139: Torvik A, Linboe CF, Rogde S. Brain lesions in alcoholics. A neuropathological study with clinical correlations. J Neurol Sci 1982;56(2-3):233-48. PMID 7175549
140: Tyrmi JS, Kaartokallio T, Lokki AI, et al. Genetic risk factors associated with preeclampsia and hypertensive disorders of pregnancy. JAMA Cardiol 2023;8(7):674-83. PMID 37285119
141: Ueno S, Takeda J, Maruyama Y, Makino S, Miyamoto N, Itakura A. Antepartum eclampsia with reversible cerebral vasoconstriction and posterior reversible encephalopathy syndromes. J Obstet Gynaecol Res 2020;46(10):2147-52. PMID 32779348
142: US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for preeclampsia: US Preventive Services Task Force recommendation statement. JAMA 2017;317(16):1661-7. PMID 28444286
143: Verhaart WJ, Daamen CB, Van Unnik JA. Polio-encephalopathia hemorrhagica superior (Wernicke's disease) in hyperemesis gravidarum and carcinoma ventriculi [Article in Dutch]. Ned Tijdschr Geneeskd 1955;99(20):1410-4. PMID 14394230
144: Victor M, Adams RD, Collins JH. The Wernicke-Korsakoff syndrome. A clinical and pathological study of 245 patients, 82 with post-mortem examinations. Contemp Neurol Ser 1971;7:1-206. PMID 5162155
145: Vilela P, Duarte J, Goulão A. Cerebrovascular disease in pregnancy and puerperium [Article in Portuguese]. Acta Med Port 2001;14(1):49-54. PMID 11321977
146: Wahood W, Rizvi AA, Alexander AY, et al. Trends in admissions and outcomes for treatment of aneurysmal subarachnoid hemorrhage in the United States. Neurocrit Care 2022;37(1):209-18. PMID 35304707
147: Watson AJ, Walker JF, Tomkin GH, Finn MM, Keogh JA. Acute Wernicke’s encephalopathy precipitated by glucose loading. Ir J Med Sci 1981;150(10):301-3. PMID 7319764
148: Walker JJ. Pre-eclampsia. Lancet 2000;356:1260-65. PMID 11072961
149: Weiner CP. Thrombotic microangiopathy in pregnancy and the postpartum period. Semin Hematol 1987;24:119-25. PMID 3299720
150: Wiebers DO. Subarachnoid hemorrhage in pregnancy. Semin Neurol 1988;8(3):226-9. PMID 3057554
151: Wiebers DO, Whisnant JP. The incidence of stroke among pregnant women in Rochester, Minn, 1955 through 1979. JAMA 1985;254(21):3055-7. PMID 4057528
152: World Health Organization. Maternal Mortality in 2000: Estimates Developed by WHO, UNICEF and UNFPA. Geneva: World Health Organization, 2004.
153: Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev 2010;(9):CD008148. PMID 20824872
154: Yamakawa S, Kisimoto K, Wada K, Hashimoto Y, Ueda M. A case of antepartum reversible cerebral vasoconstriction syndrome. Rinsho Shinkeigaku 2021;61(10):681-6. PMID 34565754
155: Zeeman GG. Neurologic complications of pre-eclampsia. Semin Perinatol 2009;33(3):166-172. PMID 19464507

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Adrian Marchidann MD

Dr. Marchidann of Kings County Hospital has no relevant financial relationships to disclose.
See Profile

Editor

Peter J Koehler MD PhD

Dr. Koehler of Maastricht University has no relevant financial relationships to disclose.
See Profile

Former Authors

Nerissa Ko MD (original author), Jeffrey Kutcher MD, and Kerry Hulsing MD

Patient Profile

Age range of presentation: 13 to 44 years
Sex preponderance: female>male, >2:1
Heredity: none
Population groups selectively affected: none
Occupation groups selectively affected: none

ICD & OMIM codes

ICD-9: Cerebrovascular disorders in the puerperium: 674.0

Intracranial venous sinus thrombosis: 671.5
ICD-10: Complication of the puerperium, unspecified: O90.9

Other venous complications in pregnancy: O22.8

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Pregnancy: CNS complications

Associated Disorders

Cerebrovascular disease
Cerebral venous thrombosis
Eclampsia
Pregnancy

Differential Diagnosis

cerebrovascular disease
venous thrombosis
arterial occlusion
arterial embolism
intracerebral hemorrhage
- subarachnoid hemorrhage
- space occupying lesions
- tumors
- infection from brain abscess
- meningitis
- encephalitis
- epilepsy
- complicated migraine
- metabolic disorders
- trophoblastic disease
- pheochromocytoma
- hypertensive encephalopathy
- hypoglycemia
- hypocalcemia
- water intoxication
- thrombotic thrombocytopenic purpura
- hemolytic uremic syndrome

Also Relevant

Chorea
Hypertensive intracerebral hemorrhage
Lobar hemorrhage
Moyamoya disease
Nontraumatic intracerebral hemorrhage
- Pregnancy and stroke
- Seizures associated with eclampsia
- Stroke in young adults
- Thalamic hemorrhage
- Unruptured cerebral aneurysms

Pregnancy: CNS complications …

Pregnancy: CNS complications

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Epidemiology

Prevention

Differential diagnosis

Associated or underlying disorders

Diagnostic workup

Management

Special considerations

Anesthesia

Media

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Toxic and nutritional deficiency optic neuropathies

Nystagmus

Third nerve palsy

Brain death/death by neurologic criteria

Hormonal contraception and stroke

Hepatic encephalopathy

Cervical spondylotic myelopathy

Bowel dysfunction in neurologic disorders

Pregnancy: CNS complications

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Epidemiology

Prevention

Differential diagnosis

Associated or underlying disorders

Diagnostic workup

Management

Special considerations

Anesthesia

Media

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Toxic and nutritional deficiency optic neuropathies

Nystagmus

Third nerve palsy

Brain death/death by neurologic criteria

Hormonal contraception and stroke

Hepatic encephalopathy

Cervical spondylotic myelopathy

Bowel dysfunction in neurologic disorders

This is an article preview.
Start a Free Account
to access the full version.